Listed

Kraig Biocraft Laboratories, Inc.: Form 10-Q for the period ended Sep 30, 2013

Filed with the SEC on Nov 19, 2013 and accepted by EDGAR at Nov 19, 2013, 15:23 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2013-09-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2013-07-01 to 2013-09-30$0us-gaap:SalesRevenueNet
Revenue9 months2013-01-01 to 2013-09-30$0us-gaap:SalesRevenueNet
Research and development3 months2013-07-01 to 2013-09-30$96.4kus-gaap:ResearchAndDevelopmentExpense
Research and development9 months2013-01-01 to 2013-09-30$416.4kus-gaap:ResearchAndDevelopmentExpense
Operating income3 months2013-07-01 to 2013-09-30−$940.9kus-gaap:OperatingIncomeLoss
Operating income9 months2013-01-01 to 2013-09-30−$1.5mus-gaap:OperatingIncomeLoss
Interest expense3 months2013-07-01 to 2013-09-30$16.0kus-gaap:InterestExpense
Interest expense9 months2013-01-01 to 2013-09-30$50.0kus-gaap:InterestExpense
Net income3 months2013-07-01 to 2013-09-30−$950.1kus-gaap:NetIncomeLoss
Net income9 months2013-01-01 to 2013-09-30−$1.5mus-gaap:NetIncomeLoss
Diluted EPS3 months2013-07-01 to 2013-09-30$0.00us-gaap:EarningsPerShareBasicAndDiluted
Diluted EPS9 months2013-01-01 to 2013-09-30$0.00us-gaap:EarningsPerShareBasicAndDiluted
Operating cash flow9 months2013-01-01 to 2013-09-30−$592.3kus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure9 months2013-01-01 to 2013-09-30$3.5kus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2013-09-30$179.7kus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2013-09-30$180.9kus-gaap:AssetsCurrent
Total assetsAt period end2013-09-30$196.6kus-gaap:Assets
Current liabilitiesAt period end2013-09-30$1.4mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2013-09-30$1.4mus-gaap:Liabilities
Shareholders' equityAt period end2013-09-30−$1.2mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001354488-13-006518. Last ingested by Listed: Oct 24, 2026, 15:09 ET. Listed shows no prices and gives no investment advice.